Dietary supplementation with trigonelline, a compound found in fenugreek seeds and coffee beans, may boost NAD+ levels, enhance muscle strength and prevent fatigue during aging, says a new study from Nestlé Research.
The ‘ecology of strains’ is imperative to consider in the research of the infant microbiome, as not all Bifidobacterium strains work equally, Dr. Bernard Berger, R&D expert microbiome and probiotics at Nestlé Research told NutraIngredients.
Swiss longevity biotech company Timeline (parent company Amazentis) announced that it has raised CHF 56 million (US$ 66 million) in an oversubscribed Series D financing round that included strategic investments by L’Oréal and Nestlé.
Nutritional supplementation could support developmental myelination, a critical process in learning and development, in growing infants and young children, according to a new industry funded study.
Personalised nutrition innovators need to better consider the entire ecosystem spanning health data collection and analysis, alongside new products, says an industry expert from Nestle.
Nestlé scientists are among a team that has detected novel gut bacteria present in the transition from infancy to early childhood. The Swiss company tells FoodNavigator it hopes the discovery will advance innovation that supports childhood development...
Three novel groups of Bifidobacterium longum have been found to grow in numbers when infants are introduced to solid foods during the weaning period, said a new study from Nestle.
Nestle has launched China’s first Foods for Special Medical Purpose (FSMP) for patients suffering from tumour related conditions, after going through a five-year long approval process from the Chinese regulator.
Infant formula’s growing ability to shift the gut microbiome closer to that of breastfed infants is outlined in a study that details how a blend of five human milk oligosaccharides (HMOs) work in tandem with each other.
Specific probiotics strains have showed immunomodulatory properties in women suffering from chronic inflammatory conditions, such as gestational diabetes and PCOS, according to a review of RCTs conducted by Nestle.
Nestle Health Science is set to acquire dietary supplement brand GO Healthy alongside the brand’s New Zealand-based parent company, it added that the GO Health brand enjoyed a unique position in the market with its “simplified yet effective” vitamin regimen.
Nestlé Germany says it shares a “common path” with herb and spice manufacturer Ankerkraut, following the acquisition of a majority stake in the company earlier this month.
The transaction is the latest move by Nestlé CEO Mark Schneider, who has received high praise from investors and analysts for his portfolio transformation over the last 5 years.
We spoke with industry experts from Nestle, Morinaga, Max Biocare and Shiseido to find out their 2022 predictions for health and nutrition trends, spanning insights across healthy ageing, infant nutrition, kids’, women’s, and men’s health.
A trial funded by Nestle has found that infant formula enriched with milk-derived oligosaccharides (MOS), a prebiotic, has helped to improve gut microbiota in babies, such as increasing the abundance of Bifidobacterium.
Nestlé makes available a report outlining efforts to comply with formula marketing guidelines that in recent years has been a subject of contention for the owners of the Gerber and NAN baby food brands.
The Access to Nutrition Initiative (ATNI) has announced that Danone has topped the 2021 list of Breast Milk Substitute (BMS) makers, scoring highly on its approach to responsible marketing.
The European Food and Safety Authority (EFSA) has rejected claims a peptide blend included in infant formula could reduce the risk of developing atopic dermatitis.
The Swiss food giant has confirmed it will update its nutrition and health strategy after British newspaper the Financial Times published leaked internal documents acknowledging that nearly 70% of its main food and drinks products, making up about half...
Chr. Hansen and Nestlé have settled a legal dispute involving alleged infringements on Human Milk Oligosaccharide (HMO) patents arising from October 2020’s acquisition of Jennewein Biotechnologie.
As 2021 approaches Spring, April sees a number of recalls concerning food and supplements that involve an infant formula product and a fibre-based supplement.
Personalized nutrition subscription company Persona Nutrition is now offering daily gummy vitamin packs for the entire family. The packs target health goals specifically for child, teen and adult wellness.
Nestlé is launching a milk product for adults, consisting of a unique combination of ingredients supporting what the company said are the three pillars of mobility: bone health, muscle strength and joint functionality.
A Nestlé-produced ketogenic (kMCT) drink could improve cognitive function in individuals suffering from Mild Cognitive Impairment (MCI), the firm's study suggests, as the product is set to be launched in Europe by the end of the year.
Given that most of the Summer months were in lockdown, August and September were surprisingly busy months for acquisitions and collaborations. Here, NutraIngredients rounds up the best of them.
Nestlé is to re-examine its policy and procedures regarding the marketing of breastmilk substitutes after a 2019 internal report identifies 107 instances of non-compliance.
Diabetic patients who adopt a nutrition therapy consisting of whey protein and monounsaturated fatty acids (MUFA) have lower fasting blood glucose during the one-month long Ramadan fasting period, a clinical trial in Malaysia has shown.
The raft of technologies and digital tools used in Personalised Nutrition (PN) represents a scalable approach that could help transition to a service based on individual prevention and self‐care.
A Nestle-EpiGen joint study found that mitochondria bioenergetics dysfunction is key in the development of sarcopenia and that the condition could be managed by improving mitochondria function.
Nestlé Health Science’s (NHSc) personalised vitamin subscription program, Persona is now available worldwide, with consumers from the UK, France and Germany among others set to benefit.
Nestlé Health Science is to form a partnership with Valbiotis to develop TOTUM-63 - the French firm’s combination of plant extracts designed to reduce the risk of developing type 2 diabetes.
The likes of Nestle, Apple and 23andMe are spearheading the drive towards Personalised Nutrition (PN) that could see the sector become the next plant-based meat, according to investment bank UBS.
Nestlé Health Science and Codexis are to extend a gut health-focused pact that sees the two firms continue to develop a lead candidate to address the gastrointestinal (GI) disorder phenylketonuria.
Jennewein Biotechnologie has filed a patent infringement suit against Nestlé concerning the unauthorised use of a human milk oligosaccharide (HMO) purification method for infant formula.
See December's 10 most read health and nutrition stories, including Nestlé Health Science China's new product innovation centre, FANCL launching its first cold care supplement, and new nutritional labelling requirements from Taiwan FDA.
Nestlé continues to accelerate its efforts in microbiome research as the Swiss multinational announces a partnership with the University of California San Diego Center for Microbiome Innovation (CMI).
Nestlé are to join a group that looks to build a global innovation ecosystem on food and nutrition specifically promoting start-ups and investment to the Swiss region.
Nestlé, Givaudan and Bühler have teamed with Swiss research institutions to address hunger, affordable nutrition and sustainable packaging across the food chain.
The Swiss food and beverage giant and the Dublin-based biotech company are to work together on discovering bioactive peptide networks in target high-value areas.
This year was a year of big M&A announcements. In case you missed it, we've compiled a short round-up of some major merges and acquisitions relevant to the dietary supplement industry:
The world’s biggest infant formula maker Nestlé has backed a World Health Organisation (WHO) statement supporting exclusive breastfeeding of infants until the age of six months.
Nestlé and the EpiGen Global Research Consortium are to begin work on an 1,800-strong epigenetics study into the impact of maternal diet on infant genes and health – something the company claims is a clinical trial first.